Hills Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.14M Buy
3,419
+242
+8% +$245K 0.15% 71
2025
Q4
$3.41M Buy
3,177
+196
+7% +$187K 0.2% 67
2025
Q3
$2.27M Sell
2,981
-148
-5% -$110K 0.13% 94
2025
Q2
$2.44M Sell
3,129
-65
-2% -$50.5K 0.15% 87
2025
Q1
$2.64M Sell
3,194
-220
-6% -$183K 0.19% 81
2024
Q4
$2.64M Sell
3,414
-331
-9% -$274K 0.2% 77
2024
Q3
$3.32M Buy
3,745
+360
+11% +$324K 0.25% 70
2024
Q2
$3.06M Buy
3,385
+41
+1% +$32.8K 0.25% 67
2024
Q1
$2.6M Buy
3,344
+199
+6% +$142K 0.22% 75
2023
Q4
$1.83M Sell
3,145
-229
-7% -$134K 0.18% 89
2023
Q3
$1.81M Sell
3,374
-911
-21% -$469K 0.21% 82
2023
Q2
$2.01M Sell
4,285
-348
-8% -$146K 0.26% 68
2023
Q1
$1.59M Sell
4,633
-587
-11% -$198K 0.22% 77
2022
Q4
$1.91M Sell
5,220
-707
-12% -$251K 0.28% 64
2022
Q3
$1.92M Sell
5,927
-1,147
-16% -$363K 0.28% 61
2022
Q2
$2.29M Sell
7,074
-783
-10% -$235K 0.37% 53
2022
Q1
$2.25M Buy
7,857
+30
+0.4% +$7.72K 0.32% 61
2021
Q4
$2.16M Buy
7,827
+236
+3% +$59.8K 0.3% 67
2021
Q3
$1.75M Buy
7,591
+598
+9% +$148K 0.27% 71
2021
Q2
$1.6M Buy
6,993
+32
+0.5% +$6.43K 0.24% 78
2021
Q1
$1.3M Buy
6,961
+183
+3% +$35.8K 0.21% 86
2020
Q4
$1.14M Buy
6,778
+459
+7% +$68.5K 0.2% 91
2020
Q3
$935K Buy
6,319
+1,330
+27% +$206K 0.18% 94
2020
Q2
$819K Buy
4,989
+340
+7% +$52.2K 0.17% 96
2020
Q1
$645K Buy
4,649
+877
+23% +$120K 0.19% 83
2019
Q4
$496K Buy
3,772
+595
+19% +$69K 0.12% 106
2019
Q3
$355K Buy
3,177
+1,194
+60% +$133K 0.09% 119
2019
Q2
$220K Buy
1,983
+157
+9% +$18.5K 0.06% 151
2019
Q1
$237K Hold
1,826
0.06% 146
2018
Q4
$212K Buy
+1,826
New +$204K 0.07% 135

Other funds holding LLY

Hills Bank & Trust's LLY Position: Q1 2026 in Review

Hills Bank & Trust increased its Eli Lilly (LLY) stake by 7.6% in Q1 2026, buying an estimated $245K and bringing the position to 3,419 shares worth $3.14M. The position accounts for 0.15% of the portfolio, ranked #71.

Hills Bank & Trust first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.41M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hills Bank & Trust held 3,419 shares of Eli Lilly worth $3.14M as of Q1 2026.
  • Hills Bank & Trust bought 242 Eli Lilly shares in Q1 2026, an estimated $245K.
  • Eli Lilly made up 0.15% of Hills Bank & Trust's portfolio in Q1 2026, its #71 holding.
  • Hills Bank & Trust first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Hills Bank & Trust's Eli Lilly position peaked at $3.41M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.